» Authors » Moustafa S Abusaif

Moustafa S Abusaif

Explore the profile of Moustafa S Abusaif including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 51
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Barakat A, Ehagali G, Kamoun E, Abusaif M, Owda M, Ghazy M, et al.
Carbohydr Polym . 2025 Jan; 352():123205. PMID: 39843106
This study aims to enhance the antimicrobial properties of chitosan through preparing novel chitosan Schiff bases via coupling with 4-formylphenyl 2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonate (B5) where, different molar ratios of B5 were used...
2.
Elsisi D, Abusaif M, El-Said E, Elqady E, Salem M, Ammar Y, et al.
RSC Adv . 2025 Jan; 15(2):1391-1406. PMID: 39822566
Herein, novel thiazolo[4,5-]quinoxalin-2-ones 2-6 and thiazolo[4,5-]quinoxalin-2(3)-imines 7-9 were synthesized and characterized using elemental analysis, IR spectroscopy, and H/C NMR to confirm their structures. The efficacy of the newly designed thiazolo-quinoxalines...
3.
Abusaif M, Ragab A, Fayed E, Ammar Y, Gowifel A, Hassanin S, et al.
Bioorg Chem . 2024 Dec; 154:108023. PMID: 39644617
Hepatocellular carcinoma (HCC) ranks as the third most prevalent reason for cancer-related death on a global scale. Tyrosine kinase inhibitors (TKIs) continue to be the primary treatment option for advanced...
4.
Omran M, Kamal M, Ammar Y, Abusaif M, Ismail M, Mansour H
Sci Rep . 2024 Aug; 14(1):19818. PMID: 39191850
A group of Niclosamide-linked isatin hybrids (Xo, X1, and X2) was created and examined using IR, HNMR, C NMR, and mass spectrometry. These hybrids' cytotoxicity, antioxidant, cell cycle analysis, and...
5.
Elnaggar E, Abusaif M, Abdel-Baky Y, Ragab A, Omer A, Ibrahim I, et al.
Int J Biol Macromol . 2024 Aug; 277(Pt 2):134347. PMID: 39094872
Chitosan is used in many applications due to its biodegradability, biocompatibility, nontoxicity, nonadhesiveness, and film-forming capabilities. Chitosan has antibacterial and antifungal activities, which are two of its other desirable attributes....
6.
Khamees Thabet H, Ammar Y, Imran M, Hamdy Helal M, Ibrahim Alaqel S, Alshehri A, et al.
Bioorg Chem . 2024 Jul; 151:107671. PMID: 39067419
Diabetes mellitus type 2 (T2DM) can be managed by targeting dipeptidyl peptidase-4 (DPP-4), an enzyme that breaks down and deactivates peptides such as GIP and GLP-1. In this context, a...
7.
Gohar N, Fayed E, Ammar Y, Abu Ali O, Ragab A, Mahfoz A, et al.
J Enzyme Inhib Med Chem . 2024 Jun; 39(1):2367128. PMID: 38913598
Inhibition of α-glucosidase and -amylase are key tactics for managing blood glucose levels. Currently, stronger, and more accessible inhibitors are needed to treat diabetes. Indeno[1,2-] quinoxalines-carrying thiazole hybrids were created...
8.
Ragab A, Elsisi D, Elqady E, El-Said E, Salem M, Ammar Y, et al.
Pestic Biochem Physiol . 2024 Jun; 202:105943. PMID: 38879303
In this study, a new series of thiazolo[4,5-b]quinoxaline derivatives 3-8 were synthesized by treating 2,3-dichloroquinoxaline with thiosemicarbazone and thiourea derivatives under reflux conditions. The chemical structure of the newly designed...
9.
Khamees Thabet H, Ragab A, Imran M, Hamdy Helal M, Ibrahim Alaqel S, Alshehri A, et al.
Eur J Med Chem . 2024 Jun; 275:116589. PMID: 38878516
Uncontrolled diabetes can lead to hyperglycemia, which causes neuropathy, heart attacks, retinopathy, and nervous system damage over time, therefore, controlling hyperglycemia using potential drug target inhibitors is a promising strategy....
10.
Ragab A, Salem M, Ammar Y, Aboulthana W, Helal M, Abusaif M
Drug Dev Res . 2024 Jun; 85(4):e22216. PMID: 38831547
A new series of quinoxaline-sulfonamide derivatives 3-12 were synthesized using fragment-based drug design by reaction of quinoxaline sulfonyl chloride (QSC) with different amines and hydrazines. The quinoxaline-sulfonamide derivatives were evaluated...